Protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease
Objective: Objective of our study was to evaluate protective and therapeutic activity of Cinnamaldehyde in the mouse model of Parkinson’s disease. Background: Parkinson’s disease (PD),…Drug-Induced Parkinsonism May Persist Beyond Two Years After Discontinuation of Dopamine Transmission Blocking Agents
Objective: To demonstrate that patients with drug-induced parkinsonism (DIP) can remain symptomatic beyond 6 months, what majority of literature suggests, after withdrawal of causative agents.…Re-emerging Neuroleptic Malignant Syndrome (NMS) without Re-introduced Neuroleptic in a Schizophrenia Patient: a Case Report
Objective: To report a case with re-emerging neuroleptic malignant syndrome (NMS) without re-introduced neuroleptic drugs. Background: Neuroleptic Malignant Syndrome (NMS) is a potentially fatal idiosyncratic…Smartphone-based gait assessment of psychiatric patients on neuroleptics
Objective: To characterize gait performance recorded from psychiatric patients on neuroleptics (PPN) and to compare it to Parkinson’s disease (PD) patients and healthy controls (HC).…Waiting and waiting on Dopamine transporter imaging in drug induced parkinsonism
Objective: We discontinued offending medications in DIP or unmasked parkinsonism patients and delayed taking DAT images for one month. Background: Drug induced parkinsonism (DIP) may…Salivary Alpha-Synuclein a new tool for the diagnosis of Parkinson’s disease?
Objective: The aim of the PARKSYN study was to test the utility of salivary alpha-synuclein (a-syn) concentration in the differential diagnosis between Parkinson's disease (PD)…Levosulpiride Induced Movement Disorder: 7 cases
Objective: Through this article we want to highlight extrapyramidal side effects of levosulpiride and need of its awareness among treating physicians. Background: Levosulpiride is a…A case of tardive dyskinesia and parkinsonism following use of phentermine for weight loss
Objective: To describe a case of tardive dyskinesia and parkinsonism following use of phentermine and briefly review the literature on tardive syndromes following use of…Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan
Objective: The calcium channel blockers, such as flunarizine and cinnarizine, and rarely selective serotonin reuptake inhibitors and lithium can produce parkinsonism and tardive syndromes. Background:…Effect of exercise on neurodegenerative parkinsonism unmasked by dopamine blocking drugs (DRBD)
Objective: To test whether aerobic walking influences clinical status, biochemical and radiologic markers associated with degenerative parkinsonism unmasked by DRBD. Background: Failed trials of putative…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »